211 related articles for article (PubMed ID: 26657080)
21. DBC1 is a negative regulator of SIRT1.
Kim JE; Chen J; Lou Z
Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501
[TBL] [Abstract][Full Text] [Related]
22. Repression of estrogen receptor beta function by putative tumor suppressor DBC1.
Koyama S; Wada-Hiraike O; Nakagawa S; Tanikawa M; Hiraike H; Miyamoto Y; Sone K; Oda K; Fukuhara H; Nakagawa K; Kato S; Yano T; Taketani Y
Biochem Biophys Res Commun; 2010 Feb; 392(3):357-62. PubMed ID: 20074560
[TBL] [Abstract][Full Text] [Related]
23. DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination.
Akande OE; Damle PK; Pop M; Sherman NE; Szomju BB; Litovchick LV; Grossman SR
Cell Rep; 2019 Mar; 26(12):3323-3335.e4. PubMed ID: 30893604
[TBL] [Abstract][Full Text] [Related]
24. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis.
Li H; Tian Z; Qu Y; Yang Q; Guan H; Shi B; Ji M; Hou P
Oncogene; 2019 Jan; 38(3):345-359. PubMed ID: 30093629
[TBL] [Abstract][Full Text] [Related]
25. CK2α phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients.
Bae JS; Park SH; Kim KM; Kwon KS; Kim CY; Lee HK; Park BH; Park HS; Lee H; Moon WS; Chung MJ; Sylvester KG; Jang KY
Int J Cancer; 2015 Feb; 136(4):797-809. PubMed ID: 24962073
[TBL] [Abstract][Full Text] [Related]
26. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
[TBL] [Abstract][Full Text] [Related]
27. Balance between SIRT1 and DBC1 expression is lost in breast cancer.
Sung JY; Kim R; Kim JE; Lee J
Cancer Sci; 2010 Jul; 101(7):1738-44. PubMed ID: 20412117
[TBL] [Abstract][Full Text] [Related]
28. DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.
Kim HJ; Moon SJ; Kim SH; Heo K; Kim JH
Cell Death Dis; 2018 Aug; 9(8):831. PubMed ID: 30082743
[TBL] [Abstract][Full Text] [Related]
29. DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcoma.
Wagle S; Park SH; Kim KM; Moon YJ; Bae JS; Kwon KS; Park HS; Lee H; Moon WS; Kim JR; Jang KY
Sci Rep; 2015 Aug; 5():13144. PubMed ID: 26249023
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma.
Li C; Liao J; Wu S; Fan J; Peng Z; Wang Z
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):511-517. PubMed ID: 29106957
[TBL] [Abstract][Full Text] [Related]
31. Advances on the role of the deleted in breast cancer (DBC1) in cancer and autoimmune diseases.
Fang Q; Bellanti JA; Zheng SG
J Leukoc Biol; 2021 Feb; 109(2):449-454. PubMed ID: 32337788
[TBL] [Abstract][Full Text] [Related]
32. ZNF326 promotes a malignant phenotype of breast cancer by interacting with DBC1.
Yu X; Wang M; Han Q; Zhang X; Mao X; Wang X; Li X; Ma W; Jin F
Mol Carcinog; 2018 Dec; 57(12):1803-1815. PubMed ID: 30175866
[TBL] [Abstract][Full Text] [Related]
33. Analysis of DBC1 and its homologs suggests a potential mechanism for regulation of sirtuin domain deacetylases by NAD metabolites.
Anantharaman V; Aravind L
Cell Cycle; 2008 May; 7(10):1467-72. PubMed ID: 18418069
[TBL] [Abstract][Full Text] [Related]
34. DBC1 is involved in adipocyte inflammation and is a possible marker of human adipose tissue senescence.
Moreno-Navarrete JM; Moreno M; Vidal M; Ortega F; Ricart W; Fernández-Real JM
Obesity (Silver Spring); 2015 Mar; 23(3):519-22. PubMed ID: 25682741
[TBL] [Abstract][Full Text] [Related]
35. DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.
Moon SJ; Jeong BC; Kim HJ; Lim JE; Kwon GY; Kim JH
Oncogene; 2018 Mar; 37(10):1326-1339. PubMed ID: 29249800
[TBL] [Abstract][Full Text] [Related]
36. The epigenetic language of circadian clocks.
Sahar S; Sassone-Corsi P
Handb Exp Pharmacol; 2013; (217):29-44. PubMed ID: 23604474
[TBL] [Abstract][Full Text] [Related]
37. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
[TBL] [Abstract][Full Text] [Related]
38. Deleted in breast cancer 1 plays a functional role in adipocyte differentiation.
Moreno-Navarrete JM; Moreno M; Vidal M; Ortega F; Serrano M; Xifra G; Ricart W; Fernández-Real JM
Am J Physiol Endocrinol Metab; 2015 Apr; 308(7):E554-61. PubMed ID: 25648830
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization, alternative splicing and expression analysis of bovine DBC1.
Li M; Sun X; Hua L; Huang Y; Wang J; Cao X; Zhan Z; Lan X; Chen H
Gene; 2013 Sep; 527(2):689-93. PubMed ID: 23845782
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1.
Liu X; Ehmed E; Li B; Dou J; Qiao X; Jiang W; Yang X; Qiao S; Wu Y
Am J Cancer Res; 2016; 6(6):1441-9. PubMed ID: 27429856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
